ANDA 88456, held by Ani Pharms. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 88456 (Thioridazine Hydrochloride), held by Ani Pharms, was first approved by FDA on May 17, 1985, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 17, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride100MG ยท tablet;oral | Thioridazine Hydrochloride | Discontinued |
| Feb 16, 1995 | Supplement 8Manufacturing | Approved | None posted |
| Oct 26, 1994 | Supplement 7Manufacturing | Approved | None posted |
| Oct 30, 1987 | Supplement 6Manufacturing | Approved | None posted |
| Apr 16, 1986 | Supplement 5Manufacturing | Approved | None posted |
| Apr 16, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Mar 21, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Mar 21, 1986 | Supplement 2Manufacturing | Approved | None posted |
| May 17, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters